GRANTS

Details of Grant policies and downloadable examples.

The TE Hubbell Kidney Cancer Warrior Institute Grants Policy Statement is intended to make available the general terms and conditions of discretionary grant and cooperative agreement awards. These general terms and conditions apply as indicated unless there are statutory, regulatory, or award-specific requirements to the contrary. This information is also designed to be useful to those interested in the grants process by providing information about that process and its associated authorities and about responsibilities. The information is contained herein and is also available as a downloadable document (see Grants Policy Statement File and Sample Grant Agreement File).

A research and/or educational grant is provided to support a research plan as presented in a grant application (including approved modifications, if any) and approved for funding by TE Hubbell Kidney Cancer Warrior Institute. The specific terms and conditions applicable to a Grant awarded by TE Hubbell Kidney Cancer Warrior Institute are set forth in these policies and procedures and the grant agreement, which incorporates by reference these policies and procedures. The grant agreement must be signed on behalf of the grantee institution (“Grantee Institution”) by an administrative official who has signatory authority and also must be signed by the principal investigator. For purposes of this policy and procedures, the Grantee Institution and Principal Investigator will be referred to as “Grantee”. In case of multiple grantee institutions or multiple investigators involved will refer collectively to all involved.
Each TE Hubbell Kidney Cancer Warrior Institute grant mechanism has unique characteristics, such as duration, funding levels, receipt designations, eligibility requirements, project requirements and authorized budget allocations. For grants submitted in response to a Request for Applications, these characteristics and requirements are detailed in the request for that grant and are incorporated by reference into the policy and procedures.
TE Hubbell Kidney Cancer Warrior Institute grants are managed through the grant program. The principal investigator and associated organization who originally submitted application materials through the TE Hubbell Kidney Cancer Warrior Institute grant system will submit the request to the grant program. All grant agreements and subsequent amendments will be executed by manual signatures.
Applicant Certification
Submission of Required Documents
Release of Final Grant Agreement
Evaluation for Duplicative Funding
Grant Effective Date
Delays in Grant Start Date
TE Hubbell Kidney Cancer Warrior Institute does not assume any responsibility for the conduct of a Research Plan or for the activities of the Principal Investigator or the Grantee Institution since they are under the scope and direction of the Grantee Institution and subject to its policies. TE Hubbell Kidney Cancer Warrior Institute does however; require that Grantee disclose at the time of application whether human subjects, human biological/anatomical materials, animals, recombinant DNA, biohazardous materials, or genetically engineered mechanisms will be utilized in the proposed research and to receive assurance that the principal investigator and the Grantee Institution will implement the necessary safeguards in the projects funded by TE Hubbell Kidney Cancer Warrior Institute.
Research Involving Human Subjects
Research Involving Human Biological/Anatomical Material
Research Involving Animals
Required Documentation
Government Compliance
TE Hubbell Kidney Cancer Warrior Institute’s policies for managing research grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard and preserving the integrity of the peer review and funding process. Throughout the term of the Grant, scientific progress will be monitored by Grant Managers assigned to the Grant. Grantee is encouraged to communicate regularly with its Grant Managers. Format and content requirements for Grant progress, financial, and final research reports are reviewed by TE Hubbell Kidney Cancer Warrior Institute annually. Grantee is responsible for reviewing and complying with all reporting requirements in effect at the time reports are due. For questions related to submissions, project and/or scientific questions Grantee should contact Grant Manager assigned to the Grant.
Quarterly and Annual Scientific Progress Reports
Research Publications
Final Research Report
Final Financial Report
Other Reports and Engagements
Non-Confidential Nature of Reports
Timely Submission of Reports
Duration
Consortia and/or Subcontracts
Ownership of Research Equipment
Payment Schedule
Payment Form
Indirect costs
Expenditures Out-of-Scope of Grant
Personnel Costs
Audits
All changes in Grant status are considered amendments to the Grant Agreement and must be submitted as changes to TE Hubbell Kidney Cancer Warrior Institute.
Changes in Research Plan
Change of Grantee Institution
Change of Personnel
Early termination by Grantee for any Reason (Except Default)
TE Hubbell Kidney Cancer Warrior Institute will release information regarding the Grant, including pictures of the Principle Investigator, as well as the research summaries, scientific progress and final reports, to the general public and news media. Grantee shall ensure that Grantee has the authority to grant KCWI the right to publish the works and photographs related to the project. Grantees are encouraged to publish the results deriving from their TE Hubbell Kidney Cancer Warrior Institute-funded research project. Grantees must release all information regarding the Grant under the following terms and conditions:
      • TE Hubbell Kidney Cancer Warrior Institute shall grant to Grantee Institution a limited, non-exclusive license to use the TE Hubbell Kidney Cancer Warrior Institute name and signature logo solely for the purpose of acknowledging TE Hubbell Kidney Cancer Warrior Institute’s funding of the project. TE Hubbell Kidney Cancer Warrior Institute will provide the Grantee Institution with camera-ready artwork of said licensed marks. TE Hubbell Kidney Cancer Warrior Institute shall retain all right, title and interest in and to the Licensed Marks, all of which shall remain the exclusive property of TE Hubbell Kidney Cancer Warrior Institute. All use of the Licensed Marks shall be in accordance with, and subject to, TE Hubbell Kidney Cancer Warrior Institute’s quality control and standard trademark guidelines. Grantee Institution shall return such artwork to TE Hubbell Kidney Cancer Warrior Institute upon completion of the project or earlier, at TE Hubbell Kidney Cancer Warrior Institute’s request.
      • Grantee Institution must acknowledge TE Hubbell Kidney Cancer Warrior Institute as a funding source on all publications and in all presentations related to the project in a clear, unambiguous, and readily-identifiable fashion, using the following acknowledgement: “This research was supported by a grant from TE Hubbell Kidney Cancer Warrior Institute”. TE Hubbell Kidney Cancer Warrior Institute reserves the right to offer grant-naming opportunities to donors and corporate partners, and depending on the Grant awarded, Grantees may be required also to acknowledge such donors or partners.
      • Grantee Institution will present to TE Hubbell Kidney Cancer Warrior Institute, prior to printing, distribution, publication, display or use, any and all promotional materials, publications, articles, pictures, press releases and scripts of all statements, oral and written, to be made by the Grantee Institution, the Principle Investigator, their agents or spokespersons, which use or refer to the Licensed Marks. Such materials and statements must reference the Licensed Marks with a registered trademark symbol, and must be of high quality consistent with Grantee Institutions’ and TE Hubbell Kidney Cancer Warrior Institute’s public image. TE Hubbell Kidney Cancer Warrior Institute shall have approval rights with respect to the use of the Licensed Marks in the materials and statements submitted by Grantee Institution. Additionally, TE Hubbell Kidney Cancer Warrior Institute may require, at its sole discretion, the removal of the Licensed Marks from any of the materials and statements at any time during the project.
      • Copies of all other news releases, articles, pictures, and any other published material, which may be developed in connection with the project or the grant, shall be furnished by Grantee Institution to TE Hubbell Kidney Cancer Warrior Institute prior to publication, or as soon thereafter as practical.
Discoveries, works of authorship, or inventions derived from research performed, supervised or subcontracted by the Principle Investigator and the Grantee Institution during the term of the Grant will be subject to TE Hubbell Kidney Cancer Warrior Institute’s Patent, Intellectual Property, and Technology Transfer Policy as set forth:
  • The primary purpose of TE Hubbell Kidney Cancer Warrior Institute in funding meritorious research is to advance its mission to find a cure for Kidney Cancer. TE Hubbell Kidney Cancer Warrior Institute recognizes, however, that Inventions (as defined below) having public health, scientific, business, or commercial application or value may be made in the course of research supported by TE Hubbell Kidney Cancer Warrior Institute. It is the desire of TE Hubbell Kidney Cancer Warrior Institute that such inventions will be administered in such a manner that they are brought into public use at the earliest possible time. TE Hubbell Kidney Cancer Warrior Institute recognizes that this may be accomplished through the filing of applications for registration of patents and/or copyrights in such inventions and the commercial licensing of such inventions to third parties.
  • All inventions shall be reported to TE Hubbell Kidney Cancer Warrior Institute in writing within three (3) months after their conception or discovery.
  • In the event that the Grantee Institution/Inventor desires to file a patent or copyright application or assert any intellectual property right in the invention, such Grantee Institution shall notify TE Hubbell Kidney Cancer Warrior Institute immediately in writing and upon TE Hubbell Kidney Cancer Warrior Institute’s request, shall provide TE Hubbell Kidney Cancer Warrior Institute with all documentation relating to the filing or assertion of rights. TE Hubbell Kidney Cancer Warrior Institute shall agree to maintain the confidentially of such documentation by executing a confidentiality agreement mutually agreed to by the Grantee Institution/Inventor and TE Hubbell Kidney Cancer Warrior Institute.
  • In the event that the Grantee Institution/Inventor contemplates entering into a license, lease, sale, assignment or revenue-generating agreement relating to the invention (collectively, a “Commercialization Agreement”), any such Commercialization Agreement shall be reviewed by TE Hubbell Kidney Cancer Warrior Institute. To the extent such agreement names TE Hubbell Kidney Cancer Warrior Institute as a party or otherwise subjects TE Hubbell Kidney Cancer Warrior Institute to potential liabilities or responsibilities, such agreement shall be approved by TE Hubbell Kidney Cancer Warrior Institute prior to execution. If the Grantee Institution has an established and applicable patent, intellectual property, or technology transfer policy, and procedure for administering inventions, TE Hubbell Kidney Cancer Warrior Institute will defer to that policy with the following restrictions:
    • TE Hubbell Kidney Cancer Warrior Institute shall be granted the non-exclusive, royalty –free license to practice the invention for non-commercial research purposes. This license will be subject to any restrictions on use or other limitations set forth in any Commercialization Agreement entered into by Grantee Institution/Inventor. TE Hubbell Kidney Cancer Warrior Institute shall participate in the income (net of any direct out-of –pocket patenting or licensing costs) derived from the invention, unless TE Hubbell Kidney Cancer Warrior Institute’s sharing of net income shall be directly proportionate to TE Hubbell Kidney Cancer Warrior Institute’s proportion of support for the research giving rise to the invention, but in no event shall exceed fifty (50%) of the total net income earned. TE Hubbell Kidney Cancer Warrior Institute waives receipt of any income until the net income from the invention exceeds $250,000.
    • No patent or patent application, copyright or other intellectual property right will be abandoned without prior notification to TE Hubbell Kidney Cancer Warrior Institute and without giving TE Hubbell Kidney Cancer Warrior Institute the opportunity to take title to the invention to the extent permitted by law.
    • The Grantee Institution/Inventor, when it licenses an invention to another party for commercialization, shall include provisions in the Commercialization Agreement obligating the licensee to commercialize the invention in a diligent manner and include appropriate diligence requirements and milestones, and shall monitor the licensee. Unless otherwise agreed by TE Hubbell Kidney Cancer Warrior Institute in writing, the Grantee Institution shall agree that:
      • If it or its licensee has not taken effective steps within (3) three years (or whatever is a reasonable longer time in the circumstances) after issuance of a patent or a clear determination of commercial value in an invention practical or commercial application through licensing or otherwise on terms that are reasonable in the circumstances; and
      • If it or its licensee cannot show reasonable cause why it or its licensee should retain title to and all rights in the administration of the invention for a further period of time, then unless no other parties have superior rights (as provided under this Policy), TE Hubbell Kidney Cancer Warrior Institute shall have the right to require the institution or its licensee: a) To license (on an exclusive basis where possible)said patent or intellectual property right to TE Hubbell Kidney Cancer Warrior Institute with the right to grant sublicenses; b) To cancel any outstanding exclusive licenses; c) To grant licenses under said patent or intellectual property right on a non-exclusive, royalty-free basis or on such other terms that are reasonable in the circumstances to third parties; and/or d) To compel such other reasonable disposition of the invention rights as may be mutually agreed upon in writing by TE Hubbell Kidney Cancer Warrior Institute and the Institution and/or its licensees. If the Grantee Institution has not established and applicable patent, intellectual property, or technology transfer policy, and procedure for administering inventions, TE Hubbell Kidney Cancer Warrior Institute shall have the sole right to determine the disposition of the invention rights in a manner consistent with this Policy. In such cases, TE Hubbell Kidney Cancer Warrior Institute may, in its sole discretion, elect to do one or more of the following: a) Have a patent and/or copyright application filed, and decide to whom it shall be assigned. In such a case, the Institution and the Inventor shall execute all documents necessary to assist in the filings and the assignment; b) Decide that patent or copyright should be or not be filed; c) Release the invention to the Inventor or Inventor’s designee; d) Submit the invention to a qualified organization for administration and licensing; e) Determine by negotiation the fair share of royalty income to be paid to the Inventor, the Grantee Institution, TE Hubbell Kidney Cancer Warrior Institute, and any other parties who contributed funds that supported the invention; or f) License or make other arrangements for the application and use of the invention on an exclusive or non-exclusive, royalty-free basis as seems reasonable in the circumstances. Notwithstanding any other provisions of this policy, if an invention is derived from research funded by the joint support of TE Hubbell Kidney Cancer Warrior Institute and an agency or department of the United States Government, TE Hubbell Kidney Cancer Warrior Institute shall defer to the patent intellectual property, or technology transfer policy of that agency or department upon written receipt of a written statement by the appropriate agency or department notifying TE Hubbell Kidney Cancer Warrior Institute of its policy and procedures and identifying the right and interests of TE Hubbell Kidney Cancer Warrior Institute in the invention. If any invention is funded by the joint support of TE Hubbell Kidney Cancer Warrior Institute and a health agency or funding organization, other than an agency or department of the United States government, and that other agency or organization has an intellectual property policy that conflicts with TE Hubbell Kidney Cancer Warrior Institute’s policy, the other agency or organization, the Inventor, the Institution, and TE Hubbell Kidney Cancer Warrior Institute shall negotiate in good faith a mutually satisfactory disposition of the invention rights. The right of TE Hubbell Kidney Cancer Warrior Institute to participate in revenue derived from an invention may only be waived in writing, and no provision of these Policies and Procedures shall constitute such a waiver.
The Grants Policy Statement is a .pdf file containing the online Grant content in a structured form that was followed in the Sample Grant Agreement.
Grants Policy Statement Download PDF file.
The following download link contains an example of a submitted Grant Agreement.
Sample Grant Agreement Download PDF file.